SavedAdd your journal

Journals / Yeni Tıp Dergisi / 2011 / Cilt: 28 - Sayı: 3

Mirtazapine bağlı ödem

Mirtazapine induced edema

Yavuz YÜCEL
Ertuğrul UZAR
Pages
191–191
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, physicians need to be aware of the potential risk of the dose related reversible edema due to mirtazapine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mirtazapine may rarely cause serious adverse effects such as edema.
📊
Key Findings & Data:Herein, we describe a patient receiving mirtazapine for depression and migraine who developed pretibial edema during treatment.
💡
Conclusion & Impact:In conclusion, physicians need to be aware of the potential risk of the dose related reversible edema due to mirtazapine.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Mirtazapine may rarely cause serious adverse effects such as edema. Herein, we describe a patient receiving mirtazapine for depression and migraine who developed pretibial edema during treatment. Pretibial edema disappeared within two days after the cessation of the therapy. In conclusion, physicians need to be aware of the potential risk of the dose related reversible edema due to mirtazapine.

Özet

Mirtazapin nadir olarak ödem gibi ciddi yan etkilere neden olabilir. Migren ve depresyon tedavisi için mirtazapin alan ve pretibial ödem gelişen bir olguyu sunduk. Mirtazapin tedavisinin kesilmesi ile 2 gün içinde pretibial ödem kayboldu. Sonuçta klinisyenlerin mirtazapine bağlı doz ile ilişkili ve geriye dönebilen ödemin farkında olmaları gereklidir.

🔖

Cite This Article

YÜCEL, Y., UZAR, E. (2011). Mirtazapine bağlı ödem. Yeni Tıp Dergisi, Cilt: 28 - Sayı: 3, 191–191. https://ajindex.com/articles/338276

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Stimmel GL, Dopheide JA, Stahl SM. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy 1997;17(1):10-21
  2. Biswas PN, Wilton LV, Shakir SAW. The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13 554 patients in England. J Psychopharmacol 2003;17(1):121–6
  3. Kutscher EC, Lund BC, Hartman BA. Peripheral edema associated with mirtazapine. Ann Pharmacother 2001;35(11):1494-5
  4. Barrnett J, Frances A, Kocsis J, Brown R, Mann JJ. Peripheral edema associated with trazodone: a report of ten cases. J Clin Psychopharmacol 1985;5(3):161-4
  5. Spina E, Santoro V, D'Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther 2008;30(7):1206-27.